Skip to content
Sign in

COSM · NASDAQ

Cosmos Health (COSM) Stock Price & Fundamentals

$369.33+0.45%+$1.67End-of-day price as of Oct 9, 2026

Cosmos Health (COSM) closed at $369.33 on Oct 9, 2026, up 0.45% from the previous close of $367.66.

Share price, past year

1Y +19.20%

52-week range $299.33 – $383.27. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$369.33
Sep 30, 2026$366.57
Aug 31, 2026$367.55
Jul 31, 2026$378.36
Jun 30, 2026$366.01
May 29, 2026$362.65
Apr 30, 2026$352.02
Mar 31, 2026$344.66
Feb 27, 2026$353.62
Jan 30, 2026$338.75
Dec 31, 2025$329.87
Nov 28, 2025$313.45
Oct 31, 2025$312.02

Key statistics

Market cap
$29.79B
P/E (TTM)
—
EPS (TTM)
−$0.66
Revenue (TTM)
$73.73M
Net income (TTM)
−$24.39M
Shares outstanding
80.7M
Dividend yield
—
52-week range
$299.33 – $383.27

Cosmos Health's market cap is $29.79B, based on a share price of $369.33 and 80.7M shares outstanding as of Jun 30, 2026.

Financials

Cosmos Health reported revenue of $65.27M for fiscal 2025, up 19.93% from fiscal 2024.

Cosmos Health reported a net loss of $19.14M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Cosmos Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$65.27M+19.9%−$19.14M−29.3%−$0.63−$8.50M
FY2024ended Dec 31, 2024$54.43M+2.0%−$16.18M−29.7%−$1.17−$8.14M
FY2023ended Dec 31, 2023$53.38M+6.0%−$18.54M−34.7%−$2.15−$16.95M
FY2022ended Dec 31, 2022$50.35M−10.5%−$13.83M−27.5%−$33.16−$14.94M
FY2021ended Dec 31, 2021$56.24M+1.5%−$7.96M−14.2%−$23.74−$7.68M
FY2020ended Dec 31, 2020$55.41M+39.7%$820.79K1.5%$0.06−$11.62M
FY2019ended Dec 31, 2019$39.68M+7.0%−$3.30M−8.3%−$0.25—
FY2018ended Dec 31, 2018$37.08M+23.6%−$9.06M−24.4%−$0.68−$2.06M
FY2017ended Dec 31, 2017$30.01M+344.3%−$6.21M−20.7%−$0.49−$8.82M
FY2016ended Dec 31, 2016$6.76M—−$601.00K−8.9%$80,741.00−$2.14M
Cosmos Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$18.99M−$6.09M−$0.10
Q1 FY2026ended Mar 31, 2026$17.93M−$2.81M−$0.06
Q4 FY2025ended Dec 31, 2025$19.70M−$10.15M−$0.33
Q3 FY2025ended Sep 30, 2025$17.11M−$5.35M−$0.17
Q2 FY2025ended Jun 30, 2025$14.75M−$2.83M−$0.10
Q1 FY2025ended Mar 31, 2025$13.71M−$818.10K−$0.03
Q4 FY2024ended Dec 31, 2024$14.22M−$3.35M−$0.46
Q3 FY2024ended Sep 30, 2024$12.41M−$8.38M−$0.45

Company profile

Name
Cosmos Health Inc.
Ticker
COSM
Exchange
NASDAQ
Industry (SEC SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Headquarters
5 Agiou Georgiou, Pilea, Thessaloniki, J3 55438
Incorporated in
NV
Fiscal year ends
December
SEC CIK
0001474167

Recent SEC filings

Frequently asked questions

What is Cosmos Health's stock price?

Cosmos Health (COSM) closed at $369.33 on Oct 9, 2026, up 0.45% from the previous close of $367.66.

What is Cosmos Health's market cap?

Cosmos Health's market cap is $29.79B, based on a share price of $369.33 and 80.7M shares outstanding as of Jun 30, 2026.

How much revenue does Cosmos Health make?

Cosmos Health reported revenue of $65.27M for fiscal 2025, up 19.93% from fiscal 2024.

Does Cosmos Health pay a dividend?

Cosmos Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Cosmos Health Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures